Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Anpac Bio-Medical Science ADR (NQ: ANPC )

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, May 19, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Anpac Bio-Medical Science ADR

< Previous 1 2 Next >
InvestorNewsBreaks – Fresh2 Group Ltd. (NASDAQ: ANPC) Ticker Symbol Change Part of Focus on New Business Line
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – Fresh2 Group Limited (NASDAQ: ANPC) Files Q1 2023, FY 2022 Financial Report
Via Investor Brand Network
Topics Economy Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Closes on $3M Registered Direct Offering
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Enters Asset Purchase Agreement with e-Commerce Food-Service Company
Via Investor Brand Network
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Enters into $3M Registered Direct Offering
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct Offering
From AnPac Bio-Medical Science Co., Ltd.
Via GlobeNewswire
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receives Approval for Continued Listing, Granted Until July 12 to Meet Equity Rule
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receive First Payment on ‘Milestone’ Purchase of Cancer Detection Equipment
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces US$5M Private Placement
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Reports Positive Results from Multiyear, Multicancer Follow-Up Study
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Acquires GISN to Enhance Efficiency of e-Commerce Operations
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Inks Acquisition Deal to Expand in the US
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Signs Agreement to Acquire a B2B Asian Food E-Commerce Platform
Via Investor Brand Network
Topics Economy Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Signs $5.2M of Definitive Investment Agreements
Via Investor Brand Network
Topics Economy Intellectual Property
Exposures Intellectual Property Supply Chain
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Releases Report Noting 48.8% Decrease in 2022 Net Loss
Via Investor Brand Network
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
AnPac Announces the Plan of US$5,000,000 Private Placement
From AnPac Bio-Medical Science Co., Ltd.
Via GlobeNewswire
AnPac Announces Strategic Initiative to Establish A Wholly-Owned Subsidiary for US Food Market
From AnPac Bio-Medical Science Co., Ltd.
Via GlobeNewswire
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Regains Compliance with Nasdaq Listing Requirement
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
AnPac Announces Regaining Compliance with Nasdaq Listing Requirement
From AnPac Bio-Medical Science Co., Ltd.
Via GlobeNewswire
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Board of Directors Sees Changes
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
AnPac Bio Announces Changes to the Board of Directors
From AnPac Bio-Medical Science Co., Ltd.
Via GlobeNewswire
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Continued Listing Status Granted by NASDAQ Hearing Panel
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
AnPac Bio Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting $1 Bid Price Compliance Rule On or Before Nov. 23, 2022
From AnPac Bio-Medical Science Co., Ltd.
Via GlobeNewswire
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Plans to Implement ADS Ratio Change
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
AnPac Bio Announces Plan to Implement ADS Ratio Change
From AnPac Bio-Medical Science Co., Ltd.
Via GlobeNewswire
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Names New Board Members, Management Changes
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
AnPac Bio Announces Board and Management Changes
From AnPac Bio-Medical Science Co., Ltd.
Via GlobeNewswire
BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC), New Investor Group Sign $3.67M Equity Investment Agreements
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces NASDAQ Delisting Appeal, Hearing
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Names New Board Members, Co-CEO
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.